Magnetic resonance imaging in prostate cancer detection and management: A systematic review

Fabio Monni, Paolo Fontanella, Angelica Grasso, Peter Wiklund, Yen Chuan Ou, Marco Randazzo, Bernardo Rocco, Emanuele Montanari, Giampaolo Bianchi

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

INTRODUCTION: The aim of our work was to evaluate the role of multi-parametric magnetic resonance imaging (mp-MRI) in detection and management of prostate cancer (PC); specifically investigating the efficacy of mpMRI-based biopsy techniques in terms of diagnostic yield of significant prostate neoplasm and the improved management of patients who choose conservative treatments or active surveillance. EVIDENCE ACQUISITION: A systematic and critical analysis through Medline, Embase, Scopus and Web of Science databases was carried out in March 2016, following the PRISMA ("Preferred Reporting Items for Systematic Reviews and Meta-Analyses") statement. The search was conducted using the following key words: "MRI/TRUS-fusion biopsy," "PIRADS," "prostate cancer," "magnetic resonance imaging (MRI)," "multiparametric MRI (mpMRI)," "systematic prostate biopsy (SB)," "targeted prostate biopsy (TPB)." English language articles were reviewed for inclusion ability. EVIDENCE SYNTHESIS: Sixty-six studies were selected in order to evaluate the characteristics and limitations of traditional sample biopsy, the role of mpMRI in detection of PC, specifically the increased degree of diagnostic accuracy of targeted prostate biopsy compared to systematic biopsy (12 cores), and to transperineal saturation biopsies with trans-rectal ultrasound (TRUS) only. MpMRI can detect index lesions in approximately 90% of cases when compared to prostatectomy specimen. The diagnostic performance of biparametric MRI (T2w + DWI) is not inferior to mpMRI, offering valid options to diminish cost- and time-consumption. Since approximately 10% of significant lesions are still MRIinvisible, systematic cores biopsy seem to still be necessary. The analysis of the different techniques shows that in-bore MRI-guided biopsy and MRI/TRUS-fusion-guided biopsy are superior in detection of significant PC compared to visual estimation alone. MpMRI proved to be very effective in active surveillance, as it prevents underdetection of significant PC and it assesses low-risk disease accurately. In higher-risk disease, presurgical MRI may change the clinically-based surgical plan in up to a third of cases. CONCLUSIONS: Targeted prostate biopsy, guided by mpMRI, is able to improve diagnostic accuracy and to reduce the detection of insignificant PC. Since the negative predictive value (NPV) of mpMRI is still imperfect, systematic cores biopsy should not be omitted for optimal staging of disease. A process of a progressive and periodic evolution in the detection and radiological classification of prostate lesions (such as PIRADS), is still needed in patients in active surveillance and in radical prostatectomy planning.

Original languageEnglish
Pages (from-to)567-578
Number of pages12
JournalMinerva Urologica e Nefrologica
Volume69
Issue number6
DOIs
Publication statusPublished - Dec 1 2017

Fingerprint

Prostatic Neoplasms
Magnetic Resonance Imaging
Biopsy
Prostate
Prostatectomy
Image-Guided Biopsy
Aptitude
Meta-Analysis
Language
Databases
Costs and Cost Analysis

Keywords

  • Biopsy.
  • Magnetic resonance imaging
  • Neoplasm staging
  • Prostatic neoplasms

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

Magnetic resonance imaging in prostate cancer detection and management : A systematic review. / Monni, Fabio; Fontanella, Paolo; Grasso, Angelica; Wiklund, Peter; Ou, Yen Chuan; Randazzo, Marco; Rocco, Bernardo; Montanari, Emanuele; Bianchi, Giampaolo.

In: Minerva Urologica e Nefrologica, Vol. 69, No. 6, 01.12.2017, p. 567-578.

Research output: Contribution to journalReview article

Monni, Fabio ; Fontanella, Paolo ; Grasso, Angelica ; Wiklund, Peter ; Ou, Yen Chuan ; Randazzo, Marco ; Rocco, Bernardo ; Montanari, Emanuele ; Bianchi, Giampaolo. / Magnetic resonance imaging in prostate cancer detection and management : A systematic review. In: Minerva Urologica e Nefrologica. 2017 ; Vol. 69, No. 6. pp. 567-578.
@article{799d6d6aa4a1450d925e25b8028abd2c,
title = "Magnetic resonance imaging in prostate cancer detection and management: A systematic review",
abstract = "INTRODUCTION: The aim of our work was to evaluate the role of multi-parametric magnetic resonance imaging (mp-MRI) in detection and management of prostate cancer (PC); specifically investigating the efficacy of mpMRI-based biopsy techniques in terms of diagnostic yield of significant prostate neoplasm and the improved management of patients who choose conservative treatments or active surveillance. EVIDENCE ACQUISITION: A systematic and critical analysis through Medline, Embase, Scopus and Web of Science databases was carried out in March 2016, following the PRISMA ({"}Preferred Reporting Items for Systematic Reviews and Meta-Analyses{"}) statement. The search was conducted using the following key words: {"}MRI/TRUS-fusion biopsy,{"} {"}PIRADS,{"} {"}prostate cancer,{"} {"}magnetic resonance imaging (MRI),{"} {"}multiparametric MRI (mpMRI),{"} {"}systematic prostate biopsy (SB),{"} {"}targeted prostate biopsy (TPB).{"} English language articles were reviewed for inclusion ability. EVIDENCE SYNTHESIS: Sixty-six studies were selected in order to evaluate the characteristics and limitations of traditional sample biopsy, the role of mpMRI in detection of PC, specifically the increased degree of diagnostic accuracy of targeted prostate biopsy compared to systematic biopsy (12 cores), and to transperineal saturation biopsies with trans-rectal ultrasound (TRUS) only. MpMRI can detect index lesions in approximately 90{\%} of cases when compared to prostatectomy specimen. The diagnostic performance of biparametric MRI (T2w + DWI) is not inferior to mpMRI, offering valid options to diminish cost- and time-consumption. Since approximately 10{\%} of significant lesions are still MRIinvisible, systematic cores biopsy seem to still be necessary. The analysis of the different techniques shows that in-bore MRI-guided biopsy and MRI/TRUS-fusion-guided biopsy are superior in detection of significant PC compared to visual estimation alone. MpMRI proved to be very effective in active surveillance, as it prevents underdetection of significant PC and it assesses low-risk disease accurately. In higher-risk disease, presurgical MRI may change the clinically-based surgical plan in up to a third of cases. CONCLUSIONS: Targeted prostate biopsy, guided by mpMRI, is able to improve diagnostic accuracy and to reduce the detection of insignificant PC. Since the negative predictive value (NPV) of mpMRI is still imperfect, systematic cores biopsy should not be omitted for optimal staging of disease. A process of a progressive and periodic evolution in the detection and radiological classification of prostate lesions (such as PIRADS), is still needed in patients in active surveillance and in radical prostatectomy planning.",
keywords = "Biopsy., Magnetic resonance imaging, Neoplasm staging, Prostatic neoplasms",
author = "Fabio Monni and Paolo Fontanella and Angelica Grasso and Peter Wiklund and Ou, {Yen Chuan} and Marco Randazzo and Bernardo Rocco and Emanuele Montanari and Giampaolo Bianchi",
year = "2017",
month = "12",
day = "1",
doi = "10.23736/S0393-2249.17.02819-3",
language = "English",
volume = "69",
pages = "567--578",
journal = "Minerva Urologica e Nefrologica",
issn = "0393-2249",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "6",

}

TY - JOUR

T1 - Magnetic resonance imaging in prostate cancer detection and management

T2 - A systematic review

AU - Monni, Fabio

AU - Fontanella, Paolo

AU - Grasso, Angelica

AU - Wiklund, Peter

AU - Ou, Yen Chuan

AU - Randazzo, Marco

AU - Rocco, Bernardo

AU - Montanari, Emanuele

AU - Bianchi, Giampaolo

PY - 2017/12/1

Y1 - 2017/12/1

N2 - INTRODUCTION: The aim of our work was to evaluate the role of multi-parametric magnetic resonance imaging (mp-MRI) in detection and management of prostate cancer (PC); specifically investigating the efficacy of mpMRI-based biopsy techniques in terms of diagnostic yield of significant prostate neoplasm and the improved management of patients who choose conservative treatments or active surveillance. EVIDENCE ACQUISITION: A systematic and critical analysis through Medline, Embase, Scopus and Web of Science databases was carried out in March 2016, following the PRISMA ("Preferred Reporting Items for Systematic Reviews and Meta-Analyses") statement. The search was conducted using the following key words: "MRI/TRUS-fusion biopsy," "PIRADS," "prostate cancer," "magnetic resonance imaging (MRI)," "multiparametric MRI (mpMRI)," "systematic prostate biopsy (SB)," "targeted prostate biopsy (TPB)." English language articles were reviewed for inclusion ability. EVIDENCE SYNTHESIS: Sixty-six studies were selected in order to evaluate the characteristics and limitations of traditional sample biopsy, the role of mpMRI in detection of PC, specifically the increased degree of diagnostic accuracy of targeted prostate biopsy compared to systematic biopsy (12 cores), and to transperineal saturation biopsies with trans-rectal ultrasound (TRUS) only. MpMRI can detect index lesions in approximately 90% of cases when compared to prostatectomy specimen. The diagnostic performance of biparametric MRI (T2w + DWI) is not inferior to mpMRI, offering valid options to diminish cost- and time-consumption. Since approximately 10% of significant lesions are still MRIinvisible, systematic cores biopsy seem to still be necessary. The analysis of the different techniques shows that in-bore MRI-guided biopsy and MRI/TRUS-fusion-guided biopsy are superior in detection of significant PC compared to visual estimation alone. MpMRI proved to be very effective in active surveillance, as it prevents underdetection of significant PC and it assesses low-risk disease accurately. In higher-risk disease, presurgical MRI may change the clinically-based surgical plan in up to a third of cases. CONCLUSIONS: Targeted prostate biopsy, guided by mpMRI, is able to improve diagnostic accuracy and to reduce the detection of insignificant PC. Since the negative predictive value (NPV) of mpMRI is still imperfect, systematic cores biopsy should not be omitted for optimal staging of disease. A process of a progressive and periodic evolution in the detection and radiological classification of prostate lesions (such as PIRADS), is still needed in patients in active surveillance and in radical prostatectomy planning.

AB - INTRODUCTION: The aim of our work was to evaluate the role of multi-parametric magnetic resonance imaging (mp-MRI) in detection and management of prostate cancer (PC); specifically investigating the efficacy of mpMRI-based biopsy techniques in terms of diagnostic yield of significant prostate neoplasm and the improved management of patients who choose conservative treatments or active surveillance. EVIDENCE ACQUISITION: A systematic and critical analysis through Medline, Embase, Scopus and Web of Science databases was carried out in March 2016, following the PRISMA ("Preferred Reporting Items for Systematic Reviews and Meta-Analyses") statement. The search was conducted using the following key words: "MRI/TRUS-fusion biopsy," "PIRADS," "prostate cancer," "magnetic resonance imaging (MRI)," "multiparametric MRI (mpMRI)," "systematic prostate biopsy (SB)," "targeted prostate biopsy (TPB)." English language articles were reviewed for inclusion ability. EVIDENCE SYNTHESIS: Sixty-six studies were selected in order to evaluate the characteristics and limitations of traditional sample biopsy, the role of mpMRI in detection of PC, specifically the increased degree of diagnostic accuracy of targeted prostate biopsy compared to systematic biopsy (12 cores), and to transperineal saturation biopsies with trans-rectal ultrasound (TRUS) only. MpMRI can detect index lesions in approximately 90% of cases when compared to prostatectomy specimen. The diagnostic performance of biparametric MRI (T2w + DWI) is not inferior to mpMRI, offering valid options to diminish cost- and time-consumption. Since approximately 10% of significant lesions are still MRIinvisible, systematic cores biopsy seem to still be necessary. The analysis of the different techniques shows that in-bore MRI-guided biopsy and MRI/TRUS-fusion-guided biopsy are superior in detection of significant PC compared to visual estimation alone. MpMRI proved to be very effective in active surveillance, as it prevents underdetection of significant PC and it assesses low-risk disease accurately. In higher-risk disease, presurgical MRI may change the clinically-based surgical plan in up to a third of cases. CONCLUSIONS: Targeted prostate biopsy, guided by mpMRI, is able to improve diagnostic accuracy and to reduce the detection of insignificant PC. Since the negative predictive value (NPV) of mpMRI is still imperfect, systematic cores biopsy should not be omitted for optimal staging of disease. A process of a progressive and periodic evolution in the detection and radiological classification of prostate lesions (such as PIRADS), is still needed in patients in active surveillance and in radical prostatectomy planning.

KW - Biopsy.

KW - Magnetic resonance imaging

KW - Neoplasm staging

KW - Prostatic neoplasms

UR - http://www.scopus.com/inward/record.url?scp=85033373013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033373013&partnerID=8YFLogxK

U2 - 10.23736/S0393-2249.17.02819-3

DO - 10.23736/S0393-2249.17.02819-3

M3 - Review article

AN - SCOPUS:85033373013

VL - 69

SP - 567

EP - 578

JO - Minerva Urologica e Nefrologica

JF - Minerva Urologica e Nefrologica

SN - 0393-2249

IS - 6

ER -